TUMOR-INFILTRATING LYMPHOCYTES IN NONLUMINAL INVASIVE DUCTAL BREAST CARCINOMA

Authors

  • L.I. Volos Danylo Halytsky Lviv National Medical University
  • A.P. Dudash Danylo Halytsky Lviv National Medical University

DOI:

https://doi.org/10.34921/amj.2022.1.021

Keywords:

tumor-infiltrating lymphocytes, breast cancer, HER-2neu, triple negative molecular subtype

Abstract

The article presents data on the features of the lymphoid microenvironment in non-luminal (HER-2neu+ and triple negative) molecular subtypes of invasive ductal breast cancer in patients without use neoadjuvant chemoradiotherapy. The purpose of this work was to assess the distribution of T and B lymphocytes and NK cells infiltrating the tumor in the non-luminal subtypes of invasive ductal breast cancer.

A histological, immunohistochemical and morphometric study of 71 cases of invasive non-luminal ductal breast cancer was carried out, of which Her2 / neu + molecular subtype included 39 cases and triple negative - 32 cases.

It was found that invasive non-luminal ductal breast cancer is characterized by a high density of lymphoid infiltrate, and at the invasive margin T-lymphocytes were 1.8-2.4 times more than B-lymphocytes, inside the tumor T-lymphocytes were 4,6 times more than B cells. An even greater difference was in the morphometric parameters between T-lymphocytes and NK-cells, and T-lymphocytes were detected 7.5-6.9 times more than NK-cells at the invasive margin, and 11.5-14 times more inside tumors in HER-2neu + and triple negative cancers, respectively.

Downloads

Download data is not yet available.

Published

2022-03-25

How to Cite

Volos, L., & Dudash, A. (2022). TUMOR-INFILTRATING LYMPHOCYTES IN NONLUMINAL INVASIVE DUCTAL BREAST CARCINOMA. Azerbaijan Medical Journal, (1), 131–137. https://doi.org/10.34921/amj.2022.1.021

Issue

Section

EXPERIMENTAL AND THEORETICAL MEDICINE